Close Menu

FDA

LabCorp becomes the first clinical lab firm in the US to offer the recently FDA-cleared HCV test.

The agency and the consortium will make available genomic data about drug-induced reactions causing skin rashes.

The molecular diagnostics firm's decline in sales to clinical partners and biothreat customers was the primary cause of its expected decrease in Q4 revenues. It also announced a series of measures aimed at reining in costs in 2009.

A company official said Hong Kong may be the best place to conduct the phase I study since data collected may be used in both US and Chinese regulatory filings.

The agency has created a new science spot to coordinate and upgrade its genomics programs.

Without specific guidance from the FDA regarding KRAS testing, drugmakers Bristol-Myers Squibb and Amgen are facing lower sales of their colorectal cancer drugs Erbitux and Vectibix, and may need to get creative in how they market their drugs to patients and doctors.

Navigenics’ lower-priced program to incorporate genetic risk data in patients’ annual medical checkup raises questions as to whether personal genomics firms should be broadly marketing their services to physicians.

Details of the deal are sparse, but the partners said they hope their research will lead to the development of genetic tests that can gauge patients’ predisposition to rare diseases and help target individuals most likely to respond to drugs made by MondoBiotech.

Researchers from the Netherlands have uncovered a new gene expression signature linked to ovarian cancer survival that is providing hints about potential pathways of importance for the disease. But authors warn that using such signatures for guiding treatment may be a ways off.

The AdvanDx test identifies E. coli and P. aeruginosa directly from positive blood cultures.

Pages

NPR reports that many USDA researchers working at the two agencies that are relocating to the Kansas City area are declining to go.

Genetic genealogy has helped exonerate a man who has been jailed for 20 years, Agence France Presse reports.

A new report says genetically modified food might be necessary to be able to feed a planet of nearly 10 billion people, Bloomberg says.

In Nature this week: new RNA editing approach called LEAPER, draft assembly of Musa balbisiana banana genome, and more.